As of 2023, Germany led with medicament exports valued at 48.6 billion USD, followed by Switzerland at 39.95 billion USD, and Belgium at 26.47 billion USD. France and the United States rounded out the top five with values of 22.78 and 22.52 billion USD, respectively.
From 2022 to 2023, Germany saw a notable increase in exports, reflecting a growing demand. Switzerland and Belgium maintained steady performance, while the United States experienced a modest decline. The compound annual growth rate over the past five years for these exporters suggests consistent growth in the European region.
Future trends to watch include potential impacts from global economic changes, regional trade policies, and innovation in pharmaceutical technologies. Regulations in key markets might also affect growth patterns, alongside increased competition from emerging markets like India.
Top countries in Top Exporters of Medicaments for Therapeutic, Prophylactic Use, in Dosage
| # | 10 Countries | Million US Dollars | Last Year | |
|---|---|---|---|---|
| 1 | 1 Germany | 48,600 | 2016 | |
| 2 | 2 Switzerland | 39,950 | 2016 | |
| 3 | 3 Belgium | 26,470 | 2016 | |
| 4 | 4 France | 22,780 | 2016 | |
| 5 | 5 United States | 22,520 | 2016 | |
| 6 | 6 United Kingdom | 21,760 | 2016 | |
| 7 | 7 Ireland | 19,770 | 2016 | |
| 8 | 8 Italy | 16,640 | 2016 | |
| 9 | 9 Netherlands | 13,580 | 2016 | |
| 10 | 10 India | 11,610 | 2016 |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
